The PCI Center

Filter Your Results

 

News

 

Postmarket Registry Evaluates B. Braun's Coroflex Isar Sirolimus-Eluting Stent

June 26, 2017 -- Findings from postmarket surveillance of the Coroflex Isar drug-coated stent (B. Braun Melsungen AG) for the treatment of real-world patients with de novo and…

Five-Year Results Published From the COMPARE II Trial of Terumo's Nobori Biodegradable DES

June 26, 2017 -- The final 5-year report from the COMPARE II trial of an abluminal biodegradable polymer biolimus-A9 -- eluting stent (BP-BES) versus a durable polymer everoli…

Two-Year Results Published From the ISAR-ABSORB Registry of Everolimus-Eluting Bioresorbable Stents in Routine Practice

June 26, 2017 -- Two-year clinical outcomes from the ISAR-ABSORB registry of patients treated in routine practice with everolimus-eluting bioresorbable stent (BRS) implantatio…

Antegrade Dissection and Reentry Technique Evaluated With Boston Scientific's CrossBoss and Stingray Devices for Hybrid CTO Treatment

June 19, 2017 -- Findings from a subanalysis of the RECHARGE registry that sought to evaluate antegrade dissection and reentry (ADR) as part of the hybrid chronic total occlus…

PREVAS Determines Vascular Access Preference of Patients Undergoing Elective Coronary Procedures

June 19, 2017 -- Online in Catheterization and Cardiovascular Interventions, Marlies M. Kok, MD, et al published findings from the PREVAS study of patient preference for radia…

Study Finds No Difference in Outcomes of Transradial PCI in STEMI Patients Treated With Bivalirudin Versus Heparin

June 12, 2017 -- Ion S. Jovin, MD, et al published a report from the National Cardiovascular Data Registry (NCDR) that evaluated bivalirudin versus heparin as anticoagulant ag…

PCI Outcomes Evaluated in Relation to Procedural Characteristics and Operator Volumes

June 12, 2017 -- In a study published in Journal of the American College of Cardiology (JACC), Alexander C. Fanaroff, MD, et al describe percutaneous coronary interv…

Risk Score Developed to Predict 30-Day Readmission After PCI

June 2, 2017 -- Findings on the development and validation of a simple risk score to predict 30-day readmission after percutaneous coronary intervention (PCI) in a cohort of M…

 

advertisement

 

Contact Info

For advertising rates and opportunities, contact:
Craig McChesney
484-581-1816
cmcchesney@bmctoday.com

Stephen Hoerst
484-581-1817
shoerst@bmctoday.com

Charles Philip
484-581-1873
cphillip@bmctoday.com

About Cardiac Interventions Today

Cardiac Interventions Today (ISSN 2572-5955 print and ISSN 2572-5963 online) is a publication dedicated to providing comprehensive coverage of the latest developments in technology, techniques, clinical studies, and regulatory and reimbursement issues in the field of coronary and cardiac interventions. Cardiac Interventions Today premiered in March 2007 and each edition contains a variety of topics in a flexible format, including articles covering various perspectives on current clinical topics, in-depth interviews with expert physicians, overviews of available technologies, industry news, and insights into the issues affecting today's interventional cardiology practices.